Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis
- PMID: 29129562
- DOI: 10.1016/j.hlc.2017.08.026
Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis
Abstract
Background: Current epidemiological data suggests that postoperative atrial fibrillation or atrial flutter (POAF) causes significant morbidity and mortality after cardiac surgery. The literature for prophylactic management of POAF is limited, resulting in the lack of clear guidelines on management recommendations.
Aim: To examine the efficacy of prophylactic rate control agents in reducing the incidence of new-onset POAF in patients undergoing elective cardiac surgery.
Methods: Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and Medline were systematically searched for blinded randomised controlled studies (RCT) evaluating adults with no history of atrial fibrillation randomised to a pharmacological agent (either beta blocker, calcium channel blocker or digoxin), compared to placebo. Utilising Cochrane guidance, three reviewers screened, extracted and the quality of the evidence was assessed. We used a random effects meta-analysis to compare a rate-control agent with placebo.
Results: Five RCTs (688 subjects, mean age 61±8.9, 69% male) were included. Beta blocker administration prior to elective cardiac surgery significantly reduced the incidence of POAF (OR 0.43, 95%Cl [0.30-0.61], I2=0%) without significant impact on ischaemic stroke (OR 0.49, 95%Cl [0.10-2.44], I2=0%), non-fatal myocardial infarction (OR 0.76, 95%Cl [0.08-7.44], I2=0%), overall mortality (OR 0.83, 95%Cl [0.19-3.66], I2=0%), or length of stay (mean -0.96days 95%Cl [-1.49 to -0.42], I2=0%). An increased rate of bradycardic episodes was observed (OR 3.53, 95%Cl [1.22-10.23], I2=0%).
Conclusions: This review suggests that selective administration of prophylactic oral beta blockers prior to elective cardiac surgery is safe and may reduce the incidence of POAF.
Keywords: Atrial fibrillation; Atrial flutter; Beta blocker; Cardiac surgery; New onset; Prophylaxis.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis.Eur J Clin Pharmacol. 2022 Nov;78(11):1777-1790. doi: 10.1007/s00228-022-03383-2. Epub 2022 Sep 22. Eur J Clin Pharmacol. 2022. PMID: 36136141
-
Perioperative beta-blockers for preventing surgery-related mortality and morbidity.Cochrane Database Syst Rev. 2018 Mar 13;3(3):CD004476. doi: 10.1002/14651858.CD004476.pub3. Cochrane Database Syst Rev. 2018. PMID: 29533470 Free PMC article.
-
Beta-blockers for hypertension.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. doi: 10.1002/14651858.CD002003.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002003. doi: 10.1002/14651858.CD002003.pub3. PMID: 17253471 Updated.
-
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.Cochrane Database Syst Rev. 2018 Mar 2;3(3):CD011893. doi: 10.1002/14651858.CD011893.pub2. Cochrane Database Syst Rev. 2018. PMID: 29499081 Free PMC article.
-
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003611. doi: 10.1002/14651858.CD003611.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003611. doi: 10.1002/14651858.CD003611.pub3. PMID: 15495059 Updated.
Cited by
-
Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery.Cochrane Database Syst Rev. 2019 Sep 23;9(9):CD013435. doi: 10.1002/14651858.CD013435. Cochrane Database Syst Rev. 2019. PMID: 31544227 Free PMC article.
-
Contemporary personalized β-blocker management in the perioperative setting.J Anesth. 2020 Feb;34(1):115-133. doi: 10.1007/s00540-019-02691-9. Epub 2019 Oct 21. J Anesth. 2020. PMID: 31637510 Review.
-
Prevalence and risk factors of atrial fibrillation during lung and esophageal surgery: A Prospective observational study.Medicine (Baltimore). 2018 Jul;97(30):e11549. doi: 10.1097/MD.0000000000011549. Medicine (Baltimore). 2018. PMID: 30045278 Free PMC article.
-
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review.Cardiovasc Diabetol. 2023 May 24;22(1):124. doi: 10.1186/s12933-023-01860-1. Cardiovasc Diabetol. 2023. PMID: 37226247 Free PMC article.
-
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation.Pharmaceutics. 2024 Apr 8;16(4):517. doi: 10.3390/pharmaceutics16040517. Pharmaceutics. 2024. PMID: 38675178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical